The human blood platelet: A cellular model to study the degradation of thymidine and its inhibition
- 1 September 1982
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 31 (17), 2755-2759
- https://doi.org/10.1016/0006-2952(82)90129-0
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- An overview of thymidineCancer, 1980
- High‐dose intravenous and hepatic artery infusions of thymidineClinical Pharmacology & Therapeutics, 1978
- Irreversible enzyme inhibitors. 188. Inhibition of mammalian thymidine phosphorylaseJournal of Medicinal Chemistry, 1971
- Irreversible enzyme inhibitors. CLXVII. Thymidine phosphorylase. 10. On the nature and dimensions of the hydrophobic bonding region. AJournal of Medicinal Chemistry, 1970
- Differential inhibitor sensitivities of thymidine phosphorylases from E. coli and mammalian tissuesBiochemical Pharmacology, 1969
- On the Catabolism of Deoxyribonucleosides in Cells and Cell Extracts of Escherichia coliEuropean Journal of Biochemistry, 1968
- Irreversible enzyme inhibitors. CXXI. Thymidine phosphorylase. 9. Nature and dimensions of the hydrophobic bonding regionJournal of Medicinal Chemistry, 1968
- The effect of nucleosides on the phosphorolysis of thymidine by normal and phage-infected cells of E., coliBiochemical and Biophysical Research Communications, 1968
- Deoxyribosyl TransferJournal of Biological Chemistry, 1964
- The possible identity of thymidine phosphorylase and pyrimidine deoxyribosyl transferase of rat liverBiochemical and Biophysical Research Communications, 1962